{"paper_id":"ddec75ac-32d1-474f-86fb-49e7235a48ac","body_text":"Abstract\nEndometriosis (EMS) is a gynecological disease that leads to pathological conditions, which are connected to the initiation of pro-inflammatory cytokine production. Inflammation plays a vital role in the pathogenesis of EMS. The activation and formation of cytoplasmic inflammasome complexes is considered an important step of inflammation and a key regulator of pyroptosis, a form of cell death. NLR family pyrin domain containing 3 (NLRP3) inflammasome complex modulates innate immune activity and inflammation. The NLRP3 inflammasome activates cysteine protease caspase-1, which produces active pro-inflammatory interleukins (ILs), including IL-1β and IL-18. The aim of this review article was to discuss the involvement of NLRP3 inflammasome assembly and its activation in the pathophysiology of EMS and target related pathways in designing appropriate therapeutic approaches. Dysregulation of sex hormone signaling pathways was associated with over-activation of the NLPR3 inflammasome. In this study, we demonstrated the involvement of NLRP3 inflammasome signaling pathways in the pathophysiology of EMS. The manuscript also discusses the beneficial effects of targeted therapy through synthetic inhibitors of NLRP3 signaling pathways to control EMS lesions.\nSimilar content being viewed by others\nData availability\nNo datasets were generated or analyzed during the current study.\nReferences\nAgarwal N, Subramanian A (2010) Endometriosis - morphology, clinical presentations and molecular pathology. J Lab Physicians 2(1):1–9\nAhn SH, Khalaj K, Young SL, Lessey BA, Koti M, Tayade C. (2016) Immune-inflammation gene signatures in endometriosis patients. Fertility and sterility 106(6):1420–31. e7\nAkther M, Haque ME, Park J, Kang T-B, Lee K-H (2021) NLRP3 Ubiquitination-a new approach to target NLRP3 inflammasome activation. Int J Mol Sci 22(16):8780\nAl-Sabbagh M, Lam EW, Brosens JJ (2012) Mechanisms of endometrial progesterone resistance. Mol Cell Endocrinol 358(2):208–215\nAsghari S, Valizadeh A, Aghebati-Maleki L, Nouri M, Yousefi M (2018) Endometriosis: perspective, lights, and shadows of etiology. Biomed Pharmacother 106:163–174\nBattineni G, Sagaro GG, Chintalapudi N, Amenta F, Tomassoni D (2021) Tayebati SKJIJoMS. Impact of Obesity-Induced Inflammation on Cardiovascular Diseases (CVD) 22(9):4798\nBiasizzo M, Kopitar-Jerala N (2020) Interplay between NLRP3 inflammasome and autophagy. Front Immunol 11:2470\nBulletti C, Coccia ME, Battistoni S, Borini A (2010) Endometriosis and infertility. J Assist Reprod Genet 27(8):441–447\nBullon P, Manuel NJ (2017) Inflammasome as a key pathogenic mechanism in endometriosis. Curr Drug Targets 18(9):997–1002\nBulun SE, Monsavais D, Pavone ME, Dyson M, Xue Q, Attar E, et al. editors. (2012) Role of estrogen receptor-β in endometriosis. Seminars in reproductive medicine; 2012: Thieme Medical Publishers\nChan AH, Schroder K (2020) Inflammasome signaling and regulation of interleukin-1 family cytokines. J Exp Med 217(1):e20190314\nChoi J, Jo M, Lee E, Kim SE, Lee D-Y, Choi D. (2022) Inhibition of the NLRP3 inflammasome by progesterone is attenuated by abnormal autophagy induction in endometriotic cyst stromal cells: implications for endometriosis. Molecular human reproduction 28(4):gaac007\nCordone V, Ferrara F, Pecorelli A, Guiotto A, Vitale A, Amicarelli F et al (2022) The constitutive activation of TLR4-IRAK1- NFκB axis is involved in the early NLRP3 inflammasome response in peripheral blood mononuclear cells of Rett syndrome patients. Free Radical Biol Med 181:1–13\nCosin-Roger J, Simmen S, Melhem H, Atrott K, Frey-Wagner I, Hausmann M et al (2017) Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation. Nat Commun 8(1):1–13\nDai S, Zhu M, Wu R, Lin D, Huang Z, Ren L et al (2019) Lipoxin A4 suppresses IL-1β-Induced Cyclooxygenase-2 expression through inhibition of p38 MAPK activation in endometriosis. Reprod Sci 26(12):1640–1649\nD'Amico R, Fusco R, Cordaro M, Siracusa R, Peritore AF, Gugliandolo E, et al. Modulation of NLRP3 inflammasome through formyl peptide receptor 1 (Fpr-1) pathway as a new therapeutic target in bronchiolitis obliterans syndrome. Int J Mol Sci 21(6)\nDehoux J-P, Defrère S, Squifflet J, Donnez O, Polet R, Mestdagt M, et al. (2011) Is the baboon model appropriate for endometriosis studies? Fertility and sterility 96(3):728–33. e3\nDominic A, Le N-T, Takahashi M (2022) Loop between NLRP3 inflammasome and reactive oxygen species. Antioxid Redox Signal 36(10):784–796\nDyson MT, Bulun SE (2012) Cutting SRC-1 down to size in endometriosis. Nat Med 18(7):1016–1018\nEisenberg VH, Zolti M, Soriano D (2012) Is there an association between autoimmunity and endometriosis? Autoimmun Rev 11(11):806–814\nElieh Ali Komi D, Wöhrl S, Bielory L (2020) Mast cell biology at molecular level: a comprehensive review. Clinical reviews in allergy & immunology 58(3):342–65\nEllis K, Munro D, Clarke J (2022) Endometriosis is undervalued: a call to action. frontiers in global women's health 3\nFainaru O, Adini A, Benny O, Adini I, Short S, Bazinet L et al (2008) Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 22(2):522–529\nFang X, Wang Y, Zhang Y, Li Y, Kwak-Kim J, Wu L (2021) NLRP3 inflammasome and its critical role in gynecological disorders and obstetrical complications. Frontiers in Immunology :3599\nFoti PV, Farina R, Palmucci S, Vizzini IAA, Libertini N, Coronella M et al (2018) Endometriosis: clinical features, MR imaging findings and pathologic correlation. Insights Imaging 9(2):149–172\nFranchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G (2009) The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10(3):241–247\nFukui A, Mai C, Saeki S, Yamamoto M, Takeyama R, Kato T, et al. (2021) Pelvic endometriosis and natural killer cell immunity. American journal of reproductive immunology (New York, NY : 1989) 85(4):e13342\nFuldeore MJ, Soliman AM (2017) Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 Women. Gynecol Obstet Invest 82(5):453–461\nFusco R, D’Amico R, Cordaro M, Gugliandolo E, Siracusa R, Peritore AF et al (2018) Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis. Oncotarget 9(59):31355–31366\nFusco R, Siracusa R, Genovese T, Cuzzocrea S, Di Paola R (2020) Focus on the role of NLRP3 inflammasome in diseases. Int J Mol Sci 21(12):4223\nGarcía-Gómez E, Vázquez-Martínez ER, Reyes-Mayoral C, Cruz-Orozco OP, Camacho-Arroyo I, Cerbón M (2020) Regulation of inflammation pathways and inflammasome by sex steroid hormones in endometriosis. Front Endocrinol (Lausanne). 10:935\nGuo S-W (2020) Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology. Hum Reprod Update 26(3):423–449\nGuo S-W, Du Y, Liu X (2016) Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis. Hum Reprod 31(7):1462–1474\nGuo M, Bafligil C, Tapmeier T, Hubbard C, Manek S, Shang C et al (2020) Mass cytometry analysis reveals a distinct immune environment in peritoneal fluid in endometriosis: a characterisation study. BMC Med 18(1):3\nGuo X, Xu X, Li T, Yu Q, Wang J, Chen Y, et al. (2021) NLRP3 inflammasome activation of mast cells by estrogen via the nuclear-initiated signaling pathway contributes to the development of endometriosis. Frontiers in immunology. 2021;12:749979\nHafner-Bratkovič I, Pelegrín P (2018) Ion homeostasis and ion channels in NLRP3 inflammasome activation and regulation. Curr Opin Immunol 52:8–17\nHan SJ, Jung SY, Wu S-P, Hawkins SM, Park MJ, Kyo S et al (2015) Estrogen receptor β modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell 163(4):960–974\nHang Y, Tan L, Chen Q, Liu Q, Jin Y (2021) E3 ubiquitin ligase TRIM24 deficiency promotes NLRP3/caspase-1/IL-1β-mediated pyroptosis in endometriosis. Cell Biol Int 45(7):1561–1570\nHeard ME, Melnyk SB, Simmen FA, Yang Y, Pabona JMP, Simmen RCJE (2016) High-fat diet promotion of endometriosis in an immunocompetent mouse model is associated with altered peripheral and ectopic lesion redox and inflammatory status 157(7):2870-82\nHerath S, Fischer DP, Werling D, Williams EJ, Lilly ST, Dobson H, et al. (2006) Expression and function of Toll-like receptor 4 in the endometrial cells of the uterus 147(1):562–70\nHo HN, Wu MY, Yang YS (1997) Peritoneal cellular immunity and endometriosis. American journal of reproductive immunology (New York, NY : 1989). 38(6):400–12\nHogg C, Horne AW, Greaves E (2020) Endometriosis-associated macrophages: origin, phenotype, and function. Front Endocrinol (lausanne) 11:7\nHuang F, Cao J, Liu Q, Zou Y, Li H, Yin T (2013) MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1β induced in human endometriosis stromal cells in vitro. Int J Clin Exp Pathol 6(10):2129\nHussein M, Chai DC, Kyama CM, Mwenda JM, Palmer SS, Gotteland J-P, et al. (2016) c-Jun NH2-terminal kinase inhibitor bentamapimod reduces induced endometriosis in baboons: an assessor-blind placebo-controlled randomized study 105(3):815–24. e5\nIto F, Yamada Y, Shigemitsu A, Akinishi M, Kaniwa H, Miyake R, et al. (2017) Role of oxidative stress in epigenetic modification in endometriosis 24(11):1493-502\nIzumi G, Koga K, Takamura M, Makabe T, Satake E, Takeuchi A et al (2018) Involvement of immune cells in the pathogenesis of endometriosis. J Obstet Gynaecol Res 44(2):191–198\nJohnson NP, Hummelshoj L, Consortium WESM, Abrao M, Adamson G, Allaire C, et al. (2013) Consensus on current management of endometriosis. Human reproduction 28(6):1552–68\nJorquera G, Russell J, Monsalves-Álvarez M, Cruz G, Valladares-Ide D, Basualto-Alarcón C, et al. (2021) NLRP3 inflammasome: potential role in obesity related low-grade inflammation and insulin resistance in skeletal muscle 22(6):3254\nJuliana C, Fernandes-Alnemri T, Wu J, Datta P, Solorzano L, Yu J-W et al (2010) Anti-inflammatory compounds parthenolide and Bay 11–7082 are direct inhibitors of the inflammasome. J Biol Chem 285(13):9792–9802\nKajihara H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, et al. (2011) New insights into the pathophysiology of endometriosis: from chronic inflammation to danger signal. 27(2):73-9\nKapoor R, Stratopoulou CA, Dolmans M-M (2021) Pathogenesis of endometriosis: new insights into prospective therapies. Int J Mol Sci 22(21):11700\nKawai T, Akira S (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13(11):460–469\nKawasaki T, Kawai T. Toll-like receptor signaling pathways. Frontiers in immunology. 2014:461.\nKelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20(13):3328\nKhan KN, Yamamoto K, Fujishita A, Muto H, Koshiba A, Kuroboshi H et al (2019) Differential levels of regulatory T cells and T-helper-17 cells in women with early and advanced endometriosis. J Clin Endocrinol Metab 104(10):4715–4729\nKhan KN, Kitajima M, Hiraki K, Yamaguchi N, Katamine S, Matsuyama T, et al. (2010) Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. 94(7):2860–3. e3\nKim EH, Park MJ, Park S, Lee ES (2015) Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease. Journal of Inflammation (london, England) 12:41\nKusama K, Fukushima Y, Yoshida K, Sakakibara H, Tsubata N, Yoshie M, et al. (2021) Endometrial epithelial-mesenchymal transition (EMT) by menstruation-related inflammatory factors during hypoxia. Molecular human reproduction 27(6)\nLee C, Do HTT, Her J, Kim Y, Seo D, Rhee I (2019) Inflammasome as a promising therapeutic target for cancer. Life Sci 231:116593\nLi T, Wang J, Guo X, Yu Q, Ding S, Xu X, et al. (2020) Possible involvement of crosstalk between endometrial cells and mast cells in the development of endometriosis via CCL8/CCR1. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 129:110476\nLi D, Wu M (2021) Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 6(1):291\nLin Y-H, Chen Y-H, Chang H-Y, Au H-K, Tzeng C-R, Huang Y-H (2018) Chronic niche inflammation in endometriosis-associated infertility: current understanding and future therapeutic strategies. Int J Mol Sci 19(8):2385\nLiu Y, Liang S, Yang F, Sun Y, Niu L, Ren Y et al (2020) Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis. Stem Cell Res Ther 11(1):346\nLyons DO, Pullen NA (2020) Beyond IgE: alternative mast cell activation across different disease states. Int J Mol Sci. 2020;21(4)\nMacer ML, Taylor HS (2012) Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstetrics and Gynecology Clinics 39(4):535–549\nMachairiotis N, Vasilakaki S, Thomakos N (2021) Inflammatory mediators and pain in endometriosis: a systematic review. Biomedicines 9(1):54\nMalutan AM, Drugan T, Costin N, Ciortea R, Bucuri C, Rada MP et al (2015) Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis. Cent Eur J Immunol 40(1):96–102\nMathiak G, Grass G, Herzmann T, Luebke T, Zetina CC, Boehm SA et al (2000) Caspase-1-inhibitor ac-YVAD-cmk reduces LPS-lethality in rats without affecting haematology or cytokine responses. Br J Pharmacol 131(3):383–386\nMehrannia K, Mokhtari T, Mogehi SMHN, Akbari M, Bazzaz JT, Mahakizeh S, et al. (2018) Intracerebroventricular injection of Wharton’s jelly mesenchymal stem cells attenuates brain damage in rat model of hypoxia: optimization of vascular endothelial growth factor and downregulation of inflammatory factors. J Contemp Med Sci| 4(3):134–9\nMishra AR, Zheng J, Tang X, Goering PL (2016) Silver nanoparticle-induced autophagic-lysosomal disruption and NLRP3-inflammasome activation in HepG2 cells is size-dependent. Toxicol Sci 150(2):473–487\nMishra SR, Mahapatra KK, Behera BP, Patra S, Bhol CS, Panigrahi DP et al (2021) Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics. Int J Biochem Cell Biol 136:106013\nMissmer SA, Chavarro JE, Malspeis S, Bertone-Johnson ER, Hornstein MD, Spiegelman D et al (2010) A Prospective Study of Dietary Fat Consumption and Endometriosis Risk 25(6):1528–1535\nMohammed I, Ijaz S, Mokhtari T, Gholaminejhad M, Mahdavipour M, Jameie B et al (2020) Subventricular zone-derived extracellular vesicles promote functional recovery in rat model of spinal cord injury by inhibition of NLRP3 inflammasome complex formation. Metab Brain Dis 35(5):809–818\nMurakami M, Osuka S, Muraoka A, Hayashi S, Bayasula, Kasahara Y, et al. (2022) Effectiveness of NLRP3 inhibitor as a non-hormonal treatment for ovarian endometriosis. Reproductive Biology and Endocrinology 20(1):58\nNagai T, Ishida C, Nakamura T, Iwase A, Mori M, Murase T et al (2020) Focal adhesion kinase-mediated sequences, including cell adhesion, inflammatory response, and fibrosis, as a therapeutic target in endometriosis. Reprod Sci 27(7):1400–1410\nNava-González EJ, de la Garza-Casas YE, Salazar-Montalvo RG, Gallegos-Cabriales EC (2013) Relationship among anthropometric and gluco-metabolic parameters, bone mineral density and endometriosis. Revista Medica Del Instituto Mexicano Del Seguro Social 51(5):522–531\nNess RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL et al (2002) Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol 186(5):929–937\nOlkowska-Truchanowicz J, Bocian K, Maksym RB, Białoszewska A, Włodarczyk D, Baranowski W et al (2013) CD4+ CD25+ FOXP3+ regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis. Human Reproduction (oxford, England) 28(1):119–124\nPalmer SS, Altan M, Denis D, Tos EG, Gotteland JP, Osteen KG et al (2016) Bentamapimod (JNK inhibitor AS602801) induces regression of endometriotic lesions in animal models. Reproductive Sciences (thousand Oaks, Calif) 23(1):11–23\nParasar P, Ozcan P, Terry KL (2017) Endometriosis: epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep 6(1):34–41\nParkin KL, Fazleabas AT (2016) Uterine leukocyte function and dysfunction: a hypothesis on the impact of endometriosis. Am J Reprod Immunol 75(3):411–417\nPatel BG, Lenk EE, Lebovic DI, Shu Y, Yu J, Taylor RN (2018) Pathogenesis of endometriosis: Interaction between endocrine and inflammatory pathways. Best Pract Res Clin Obstet Gynaecol 50:50–60\nPiccinini AM, Midwood KS (2010) DAMPening inflammation by modulating TLR signalling. Mediators of inflammation 2010\nPrescott J, Farland L, Tobias D, Gaskins A, Spiegelman D, Chavarro J et al (2016) A prospective cohort study of endometriosis and subsequent risk of infertility. Hum Reprod 31(7):1475–1482\nRafique S, Decherney AH (2017) Medical management of endometriosis. Clin Obstet Gynecol 60(3):485–496\nde Rivero Vaccari JP. The inflammasome in reproductive biology: a promising target for novel therapies. Front Endocrinol (Lausanne). 2020:8.\nRocha ALL, Reis FM, Taylor RN (2013) Angiogenesis and endometriosis. Obstetrics and gynecology international 2013\nSagulenko V, Thygesen SJ, Sester DP, Idris A, Cridland JA, Vajjhala PR et al (2013) AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ 20(9):1149–1160\nSalliss ME, Farland LV, Mahnert ND, Herbst-Kralovetz MM (2022) The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. Hum Reprod Update 28(1):92–131\nSantoni G, Cardinali C, Morelli MB, Santoni M, Nabissi M, Amantini C (2015) Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons. J Neuroinflammation 12(1):21\nSchmidt RL, Lenz LL. (2012) Distinct licensing of IL-18 and IL-1β secretion in response to NLRP3 inflammasome activation\nSchuh E, Groß CJ, Wagner D, Schlüter M, Groß O, Kümpfel T (2019) MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants. Clinical Immunology (orlando, Fla) 203:45–52\nSeok JK, Kang HC, Cho Y-Y, Lee HS, Lee JY (2021) Regulation of the NLRP3 inflammasome by post-translational modifications and small molecules. Front Immunol 11:3877\nShah DK, Correia KF, Vitonis AF, Missmer SAJHR (2013) Body size and endometriosis: results from 20 years of follow-up within the Nurses' Health Study II prospective cohort 28(7):1783–92\nShao B-Z, Xu Z-Q, Han B-Z, Su D-F, Liu C (2015) NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol. 6:262\nSikora J, Mielczarek-Palacz A, Kondera-Anasz Z (2011) Role of natural killer cell activity in the pathogenesis of endometriosis. Curr Med Chem 18(2):200–208\nSikora J, Mielczarek-Palacz A, Kondera-Anasz Z (2012) Imbalance in cytokines from interleukin-1 family–role in pathogenesis of endometriosis. Am J Reprod Immunol 68(2):138–145\nSikora J, Smycz-Kubańska M, Mielczarek-Palacz A, Bednarek I, Kondera-Anasz Z (2018) The involvement of multifunctional TGF-β and related cytokines in pathogenesis of endometriosis. Immunol Lett 201:31–37\nSong N, Li T. Regulation of NLRP3 inflammasome by phosphorylation. Frontiers in immunology. 2018a:2305.\nSong N, Li T (2018b) Regulation of NLRP3 inflammasome by phosphorylation. Front Immunol 9:2305\nSymons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M et al (2018) The immunopathophysiology of endometriosis. Trends Mol Med 24(9):748–762\nVallée A, Lecarpentier Y (2020) Curcumin and endometriosis. Int J Mol Sci 21(7):2440\nVallvé-Juanico J, Houshdaran S, Giudice LC (2019) The endometrial immune environment of women with endometriosis. Hum Reprod Update 25(5):564–591\nWalenta L, Schmid N, Schwarzer JU, Köhn F-M, Urbanski HF, Behr R et al (2018) NLRP3 in somatic non-immune cells of rodent and primate testes. Reproduction 156(3):231–238\nWang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, et al. (2020) NLRP3 inflammasome and inflammatory diseases. Oxidative medicine and cellular longevity 2020\nWilliams A, Flavell RA, Eisenbarth SC (2010) The role of NOD-like receptors in shaping adaptive immunity. Curr Opin Immunol 22(1):34–40\nYang Y, Wang H, Kouadir M, Song H, Shi F (2019) Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis 10(2):128\nYen H, Karino M, Tobe TJFiC (2016) Microbiology I. Modulation of the inflammasome signaling pathway by enteropathogenic and enterohemorrhagic Escherichia coli 6:89\nYilmaz BD, Bulun SE (2019) Endometriosis and nuclear receptors. Hum Reprod Update 25(4):473–485\nZhao J, Ma W, Chen W, Gao J, Li C, Tong Y et al (2019) AEG-1 aggravates inflammation via promoting NALP3 inflammasome formation in murine endometriosis lesions. Animal Cells and Systems 23(6):407–413\nZhou F, Li C, Zhang S-Y (2021) NLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders? Chin Med J 134(01):20–27\nZhou F, Zhao F, Huang Q, Lin X, Zhang S, Dai Y (2022) NLRP3 activated macrophages promote endometrial stromal cells migration in endometriosis. J Reproduct Immunol. 103649\nZhu TH, Zou G, Ding SJ, Li TT, Zhu LB, Wang JZ et al (2019) Mast cell stabilizer ketotifen reduces hyperalgesia in a rodent model of surgically induced endometriosis. J Pain Res 12:1359–1369\nZou G, Wang J, Xu X, Xu P, Zhu L, Yu Q, et al. (2021) Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing. Cell Biosci. 11(1):98\nAuthor information\nAuthors and Affiliations\nContributions\nEI and SN conceived the presented idea. All the authors equally participated in drafting the article. EI and SN participated in revising it critically for important intellectual content. All the authors gave final approval of the version to be submitted and any revised version.\nCorresponding author\nEthics declarations\nEthical approval\nN/A.\nConsent to participate\nN/A.\nConsent for publication\nN/A.\nCompeting interests\nThe authors declare no competing interests.\nAdditional information\nPublisher's note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nRights and permissions\nSpringer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.\nAbout this article\nCite this article\nIrandoost, E., Najibi, S., Talebbeigi, S. et al. Focus on the role of NLRP3 inflammasome in the pathology of endometriosis: a review on molecular mechanisms and possible medical applications. Naunyn-Schmiedeberg's Arch Pharmacol 396, 621–631 (2023). https://doi.org/10.1007/s00210-022-02365-6\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s00210-022-02365-6","source_license":"CC0","license_restricted":false}